首页> 外文期刊>Therapeutic Drug Monitoring >New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients
【24h】

New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients

机译:使用贝叶斯方法评估肾移植受者碘海醇清除率的新采样策略

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Glomerular filtration rate (GFR) measurement is a major issue in kidney transplant recipients for clinicians. GFR can be determined by estimating the plasma clearance of iohexol, a nonradiolabeled compound. For practical and convenient application for patients and caregivers, it is important that a minimal number of samples are drawn. The aim of this study was to develop and validate a Bayesian model with fewer samples for reliable prediction of GFR in kidney transplant recipients. Methods: Iohexol plasma concentration-time curves from 95 patients were divided into an index (n = 63) and a validation set (n = 32). Samples (n = 4-6 per patient) were obtained during the elimination phase, that is, between 120 and 270 minutes. Individual reference values of iohexol clearance (CLiohexol) were calculated from k (elimination slope) and V (volume of distribution from intercept). Individual CLiohexol values were then introduced into the Br?chner-Mortensen equation to obtain the GFR (reference value). A population pharmacokinetic model was developed from the index set and validated using standard methods. For the validation set, we tested various combinations of 1, 2, or 3 sampling time to estimate CLiohexol. According to the different combinations tested, a maximum a posteriori Bayesian estimation of CLiohexol was obtained from population parameters. Individual estimates of GFR were compared with individual reference values through analysis of bias and precision. A capability analysis allowed us to determine the best sampling strategy for Bayesian estimation. Results: A 1-compartment model best described our data. Covariate analysis showed that uremia, serum creatinine, and age were significantly associated with ke, and weight with V. The strategy, including samples drawn at 120 and 270 minutes, allowed accurate prediction of GFR (mean bias:-3.71%, mean imprecision: 7.77%). With this strategy, about 20% of individual predictions were outside the bounds of acceptance set at ±10%, and about 6% if the bounds of acceptance were set at ±15%. Conclusions: This Bayesian approach can help to reduce the number of samples required to calculate GFR using Br?chner-Mortensen formula with good accuracy.
机译:背景:肾小球滤过率(GFR)的测量是临床医生肾脏移植接受者的主要问题。 GFR可以通过估算非放射性标记化合物碘海醇的血浆清除率来确定。为了使患者和护理人员能够方便实用地进行应用,重要的是抽取最少数量的样品。这项研究的目的是开发和验证较少样本的贝叶斯模型,以可靠地预测肾移植受者的GFR。方法:将95例患者的Iohexol血浆浓度-时间曲线分为一个指标(n = 63)和一个验证集(n = 32)。在消除阶段,即120至270分钟之间,获得了样本(每位患者n = 4-6)。根据k(消除斜率)和V(截距的分布量)计算碘海醇清除率(氯己醇)的各个参考值。然后将各个氯己醇值引入Br?chner-Mortensen方程中,以获得GFR(参考值)。从指标集建立了群体药代动力学模型,并使用标准方法进行了验证。对于验证集,我们测试了1个,2个或3个采样时间的各种组合以估计CLiohexol。根据测试的不同组合,可以从总体参数中获得最大的后苯二酚贝叶斯估计值。通过对偏差和精度进行分析,将GFR的单个估计值与单个参考值进行比较。能力分析使我们能够确定用于贝叶斯估计的最佳采样策略。结果:1室模型最能描述我们的数据。协变量分析显示尿毒症,血清肌酐和年龄与ke显着相关,体重与V显着相关。该策略(包括在120和270分钟时抽取的样本)可以准确预测GFR(平均偏倚:-3.71%,平均不准确性: 7.77%)。通过这种策略,大约20%的个人预测超出了接受范围的±10%,如果接受范围设为±15%,则只有约6%。结论:这种贝叶斯方法可以帮助减少使用Br?chner-Mortensen公式计算GFR所需的样本数量,并且准确性很高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号